XOMA Royalty Corp. (XOMA)
XOMA Stock Price Chart
Explore XOMA Royalty Corp. interactive price chart. Choose custom timeframes to analyze XOMA price movements and trends.
XOMA Company Profile
Discover essential business fundamentals and corporate details for XOMA Royalty Corp. (XOMA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
6 Jun 1986
Employees
13.00
Website
https://www.xoma.comCEO
Owen P. Hughes Jr.
Description
XOMA Royalty Corp. operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMA Financial Timeline
Browse a chronological timeline of XOMA Royalty Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.02, while revenue estimate is $11.47M.
Earnings released on 13 Aug 2025
EPS came in at $0.48 surpassing the estimated -$0.12 by +500.00%, while revenue for the quarter reached $13.13M , beating expectations by +32.32%.
Earnings released on 13 May 2025
EPS came in at $0.06 surpassing the estimated -$0.26 by +123.08%, while revenue for the quarter reached $15.91M , beating expectations by +125.22%.
Earnings released on 17 Mar 2025
EPS came in at -$0.46 falling short of the estimated -$0.29 by -58.62%, while revenue for the quarter reached $2.34M , missing expectations by -73.22%.
Earnings released on 7 Nov 2024
EPS came in at -$0.39 surpassing the estimated -$0.44 by +11.36%, while revenue for the quarter reached $7.20M , missing expectations by -17.72%.
Earnings released on 13 Aug 2024
EPS came in at -$0.28 falling short of the estimated -$0.26 by -7.69%, while revenue for the quarter reached $11.09M , beating expectations by +32.29%.
Earnings released on 9 May 2024
EPS came in at -$0.86 falling short of the estimated -$0.71 by -21.13%, while revenue for the quarter reached $1.49M , beating expectations by +12.03%.
Earnings released on 8 Mar 2024
EPS came in at -$0.49 falling short of the estimated -$0.36 by -36.11%, while revenue for the quarter reached $1.83M , missing expectations by -49.08%.
Earnings released on 7 Nov 2023
EPS came in at -$0.60 falling short of the estimated -$0.48 by -25.00%, while revenue for the quarter reached $830.00K , missing expectations by -76.94%.
Earnings released on 8 Aug 2023
EPS came in at -$0.59 falling short of the estimated -$0.52 by -13.46%, while revenue for the quarter reached $1.66M , beating expectations by +107.25%.
Earnings released on 9 May 2023
EPS came in at -$0.98 falling short of the estimated -$0.50 by -96.00%, while revenue for the quarter reached $437.00K , missing expectations by -42.50%.
Earnings released on 9 Mar 2023
EPS came in at -$0.64 falling short of the estimated $0.47 by -236.17%, while revenue for the quarter reached $1.49M , beating expectations by +40.19%.
Earnings released on 3 Nov 2022
EPS came in at -$0.48 falling short of the estimated -$0.20 by -140.00%, while revenue for the quarter reached $451.00K , missing expectations by -90.02%.
Earnings released on 4 Aug 2022
EPS came in at -$0.53 falling short of the estimated -$0.11 by -381.82%, while revenue for the quarter reached $983.00K , missing expectations by -76.98%.
Earnings released on 5 May 2022
EPS came in at -$0.32 surpassing the estimated -$0.34 by +5.88%, while revenue for the quarter reached $3.11M , missing expectations by -1.83%.
Earnings released on 8 Mar 2022
EPS came in at $1.67 falling short of the estimated $2.27 by -26.43%, while revenue for the quarter reached $35.94M , beating expectations by +2.29%.
Earnings released on 4 Nov 2021
EPS came in at -$0.51 falling short of the estimated -$0.09 by -466.67%, while revenue for the quarter reached $940.00K , missing expectations by -63.71%.
Earnings released on 5 Aug 2021
EPS came in at -$0.31 surpassing the estimated -$0.41 by +24.39%, while revenue for the quarter reached $901.00K , missing expectations by -57.30%.
Earnings released on 6 May 2021
EPS came in at -$0.70 falling short of the estimated -$0.15 by -366.67%, while revenue for the quarter reached $375.00K , missing expectations by -53.22%.
Earnings released on 10 Mar 2021
EPS came in at $1.32 falling short of the estimated $2.00 by -34.00%, while revenue for the quarter reached $27.58M .
Earnings released on 5 Nov 2020
EPS came in at -$0.10 surpassing the estimated -$0.21 by +52.38%, while revenue for the quarter reached $557.00K , missing expectations by -52.38%.
XOMA Stock Performance
Access detailed XOMA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.